Science Explorer Back to mapMap
Discussion
Researcher · IFOM · Italy

Matteo Malinverno

Matteo Malinverno publishes mostly in Neurology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Vascular Malformations Diagnosis and Treatment, Intracranial Aneurysms: Treatment and Complications and Intracerebral and Subarachnoid Hemorrhage Research.

ORCID 0000-0001-8242-7937 OpenAlex
World rank
#855,940
of 7,710,434 ranked researchers
Rank in Italy
#26,176
of 242,206
Works
42
Citations
1.5k
Citations per work
35.9
h-index
20
i10-index 25Top 24% in Neurology (Medicine)
Matteo Malinverno

What does Matteo Malinverno research?

Matteo Malinverno's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (19%), Neuroscience (8%).

Health Sciences: 21 works · 49.1% of their workMedicine: 21 works · 49.1% of their workNeurology: 17 works · 41.2% of their workSurgery: 2 works · 4.4% of their workPhysiology: 1 works · 3.5% of their workLife Sciences: 11 works · 27.2% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 19.3% of their workMolecular Biology: 7 works · 16.7% of their workCancer Research: 1 works · 2.6% of their workNeuroscience: 3 works · 7.9% of their workCellular and Molecular Neuroscience: 3 works · 7.9% of their workEverything else: 10 works · 23.7% of their workTHEIR WORKMatteo Malinverno42works
Life Sciences27%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2149.1%
    1. Biochemistry, Genetics and Molecular Biology819.3%
    2. Neuroscience37.9%
  3. Everything else1023.7%
  1. 1Neurology41% of their works
  2. 2Molecular Biology17% of their works
  3. 3Cellular and Molecular Neuroscience8% of their works
  4. 4Surgery4% of their works
  5. 5Physiology4% of their works
  6. 6Cancer Research3% of their works

Research topics

Which keywords describe Matteo Malinverno's research?

The keywords of their largest research topics: Endovascular Treatment, Arteriovenous Malformations, Cerebral Cavernous Malformations, Neuroinflammation, Aneurysmal Subarachnoid Hemorrhage, Intracranial Aneurysms, Cerebral Amyloid Angiopathy and Intracerebral Hemorrhage.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Endovascular Treatment272 topics
  2. Arteriovenous Malformations161 topic
  3. Cerebral Cavernous Malformations161 topic
  4. Neuroinflammation142 topics
  5. Aneurysmal Subarachnoid Hemorrhage111 topic
  6. Intracranial Aneurysms111 topic
  7. Cerebral Amyloid Angiopathy101 topic
  8. Intracerebral Hemorrhage101 topic
  9. Neurodegeneration92 topics
  10. Oxidative Stress92 topics
  11. Neurotransmission61 topic
  12. Synaptic Plasticity61 topic
  13. Parkinson's Disease51 topic
  14. a-Synuclein51 topic
  15. Amyloid Hypothesis41 topic
  16. Tau Pathology41 topic
  17. VEGF41 topic
  18. endothelial progenitor cells41 topic
  19. Crystal Structure31 topic
  20. G-Protein-Coupled Receptors31 topic

Where does Matteo Malinverno work?

Matteo Malinverno's main affiliation in the publication record is IFOM, Italy.

How many publications and citations does Matteo Malinverno have?

OpenAlex counts 42 works and 1,507 citations for Matteo Malinverno, an h-index of 20, ranking #855,940 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Matteo Malinverno. Posts are plain text and can be reported.